The effects of AT1R blockade on the network level were specifically associated with the transcriptomic signatures of the dopaminergic, opioid, acetylcholine, and corticotropin-releasing hormone signaling systems—neurotransmitter pathways known to be dysregulated in depressive disorder [157]. Here, AGTR1 is linked to depressive disorder.